Verition Fund Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Verition Fund Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,070	Closed	-$366K	–	2715
2023 Q1	$366K	Hold	35,070	–	–	0.01%	1402
2022 Q4	$361K	Hold	35,070	–	–	0.01%	1402
2022 Q3	$353K	Hold	35,070	–	–	﹤0.01%	2113
2022 Q2	$349K	Buy	+35,070	New	+$350K	0.01%	1659

Verition Fund Management's LVAC Position: Q2 2023 in Review

Verition Fund Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 35,070 shares — an estimated $366K sold.

Verition Fund Management first reported a position in LVAC in Q2 2022 and held it in 4 quarters. The position peaked at $366K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Verition Fund Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Verition Fund Management sold 35,070 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $366K.
Verition Fund Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Verition Fund Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $366K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Verition Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.